Equities

Inspira Technologies Oxy BHN Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
IINN:NAQ

Inspira Technologies Oxy BHN Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.5999
  • Today's Change0.000 / -0.02%
  • Shares traded427.00
  • 1 Year change-30.74%
  • Beta2.2833
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Inspira Technologies Oxy B.H.N Ltd, formerly Insense Medical Ltd, incorporated on February 27, 2018, is a specialty medical device company based in Israel. The Company is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). It provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV.

  • Revenue in USD (TTM)289.00k
  • Net income in USD-11.21m
  • Incorporated2018
  • Employees38.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Retractable Technologies Inc37.90m-6.68m20.65m221.00--0.269824.850.5449-0.223-0.2231.272.560.24921.864.43171,495.80-4.248.45-4.509.59-2.4238.19-17.0115.054.54--0.0126---24.19-4.59-67.29--17.90--
Adagio Medical Holdings Inc137.00k-79.15m20.97m86.00------153.05-4.75-4.750.0087-0.08530.0020.75583.041,593.02-114.09---130.69---1,468.61---57,771.53--0.6798-4.931.07--100.67---105.09------
Milestone Scientific Inc8.93m-6.67m22.13m17.00--8.67--2.48-0.0823-0.08230.10990.03250.90840.489614.06525,265.90-67.82-48.29-122.68-62.1471.8665.25-74.66-81.560.5103-837.640.2518---12.190.602731.97--0.40--
Jin Medical International Ltd20.69m1.19m22.35m295.0018.760.754313.761.080.00760.00760.13220.18930.41722.902.8875,777.592.798.214.7212.7229.2233.566.6812.521.65--0.38910.00-11.985.02-67.59-11.59115.60--
Global Innovative Platforms Inc30.00k-647.22k24.24m52.00--147.33--808.04-0.0156-0.01560.00070.00350.1607-------346.65---441.46-------2,157.40------0.0185-------427.35------
IRIDEX Corp50.65m-5.09m24.58m93.00------0.4854-0.3026-0.30263.020.27461.733.437.74544,591.40-17.39-20.28-33.62-29.9638.1842.41-10.04-15.171.35--0.4418---6.172.306.90---36.71--
Harvard Bioscience Inc87.37m-53.84m25.29m330.00--1.79--0.2895-1.22-1.221.980.31560.83521.587.01264,760.60-51.46-4.48-81.52-5.4756.9457.18-61.62-6.180.4081-0.56860.7071---16.14-4.12-263.25--21.83--
Inspira Technologies Oxy BHN Ltd289.00k-11.21m25.96m38.00--13.45--89.82-0.4606-0.46060.01280.04460.04170.52810.66597,605.26-161.61-109.16-302.02-145.380.692---3,879.24--0.9002--0.00------2.06--39.54--
Phaos Technlgy Hldngs (Cayman) Limited131.31k-100.00bn26.59m--------202.51-------0.0597------------------------0.3176------------------
PetVivo Holdings Inc1.11m-10.21m27.31m24.00--7.96--24.57-0.3857-0.38570.04110.09810.29690.78744.2546,318.33-265.20-195.28-557.27-346.3366.0574.58-893.26-1,163.490.787-4.520.00--16.91216.0823.33--49.21--
Myomo Inc41.64m-12.02m28.77m184.00--1.97--0.6908-0.2885-0.28851.010.38051.653.969.23226,321.70-47.71-55.96-70.30-77.4066.5669.74-28.86-52.922.10--0.2148--69.1753.3624.10--92.10--
Guided Therapeutics Inc178.00k-2.80m29.26m4.00------164.38-0.0386-0.03860.0025-0.06750.16540.108344.5044,500.00-244.61-129.80----62.9244.19-1,478.65-4,184.720.0334-4.13-----92.86-27.9331.07------
RenovoRx Inc928.00k-11.11m30.54m10.00--3.78--32.91-0.4375-0.43750.03120.22040.0874----92,800.00-104.58-121.57-126.33-166.5067.78---1,196.66-90,830.235.68--0.00------13.86------
EUDA Health Holdings Ltd5.16m-2.06m30.59m117.0052.37----5.930.01550.08760.1483-0.09982.49--17.1044,104.96-100.77------22.39---40.53--0.2084-46.54----8.22---108.62------
Femasys Inc2.06m-19.80m30.96m69.00--5.50--15.02-0.7198-0.71980.070.09630.12940.19734.3429,876.81-124.24-63.09-214.46-74.3063.0566.63-960.53-961.820.6131-9.720.5982--51.9711.89-32.07--4.01--
Vaso Corp89.11m2.59m31.24m298.0012.101.119.430.35060.01470.01470.50650.16051.1334.0210.28299,030.203.277.375.3614.5660.9159.172.915.991.61--0.01--7.092.82-80.21--3.81--
Data as of Mar 03 2026. Currency figures normalised to Inspira Technologies Oxy BHN Ltd's reporting currency: US Dollar USD

Institutional shareholders

5.88%Per cent of shares held by top holders
HolderShares% Held
Yorkville Advisors Global LPas of 31 Dec 20251.78m4.99%
Kestra Advisory Services LLCas of 31 Dec 202578.82k0.22%
XTX Markets LLCas of 31 Dec 202572.53k0.20%
UBS Securities LLCas of 31 Dec 202553.34k0.15%
G1 Execution Services LLCas of 31 Dec 202530.88k0.09%
Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 202525.93k0.07%
Two Sigma Securities LLCas of 31 Dec 202520.37k0.06%
Laidlaw Wealth Management LLCas of 31 Dec 202513.50k0.04%
StoneX Group, Inc. (Investment Management)as of 31 Dec 202510.28k0.03%
Equitable Advisors LLCas of 31 Dec 202510.00k0.03%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.